MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12951-022-01406-9

Медицинская библиотека · Journal of nanobiotechnology · 2022

Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance.

Du Bin, Zheng Mei, Ma Huizhen, Huang Jingshu, Jiao Qingqing, Bai Yimeng, Zhao Mengmeng, Zhou Jie

СтатьяПеревод пока не подготовлен

Аннотация

Multidrug resistance is still a major obstacle to cancer treatment. The most studies are to inhibit the activity of the drug transporter P-glycoprotein (P-gp), but the effect is not ideal. Herein, a nanosystem was built based on cascade catalytic consumption of cholesterol. Cholesterol oxidase (natural enzyme, COD) was immobilized on the carrier (NH2-MIL-88B, MOF) through amide reaction, COD catalyzed the consumption of cholesterol, the reaction product H2O2 was further produced by the MOF with its peroxidase-like activity to produce hydroxyl radicals (•OH) with killing effect. Due to the high expression of CD44 receptor on the surface of tumor cells, we encapsulated chondroitin sulfate gel shell (CS-shell) with CD44 targeting and apoptosis promoting effect on the surface of DOX@MOF-COD nanoparticles, which can accurately and efficiently deliver the drugs to the tumor site and improve the effect of reversing drug resistance. Taking drug-resistant cell membrane as "breakthrough", this paper will provide a new idea for reversing multidrug resistance of tumor.

Для цитирования: Du Bin, Zheng Mei, Ma Huizhen, Huang Jingshu, Jiao Qingqing, Bai Yimeng, Zhao Mengmeng, Zhou Jie. Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance.. Journal of nanobiotechnology. 2022. DOI: 10.1186/s12951-022-01406-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.